Finance

Lists
PBLA:OTCMKTS
Panbela Therapeutics Inc
USD 0,00
0,00%
(0,00) 1D
2 Okt., 15:02:31 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PBLA...
Mkt. cap
5,39
Avg. vol.
465,00
Volume
0,00
52-wk high
USD 2,50
52-wk low
USD 0,00
Beta
-0,66
Shares outstanding
4,86 m
No. of employees
7
Mkt. cap
5,39
Avg. vol.
465,00
Volume
0,00
52-wk high
USD 2,50
52-wk low
USD 0,00
Beta
-0,66
Shares outstanding
4,86 m
No. of employees
7
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
31 minute gelede
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City
The Globe and Mail
The Globe and Mail
·
59 minute gelede
U.S. Analyst Updates: October 7th, 2026
Investor's Business Daily
Investor's Business Daily
·
2 uur gelede
Futures: Memory Giant's Earnings Surge, But Miss Views
About Panbela Therapeutics Inc
CEO-
Employees7
Founded2011
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2023
Mrt. 2024
Jun. 2024
Sep. 2024
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
6,05 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
1,11 m
Operating expense
-
-
-
7,16 m
Total operating expenses
-
-
-
7,16 m
Operating income
-
-
-
-7,16 m
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-7,17 m
EBT excluding unusual items
-
-
-
-7,17 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-7,17 m
Net profit margin
-
-
-
-
Earnings per share
-65,90
-2,28
-1,47
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-442,00 k
Net interest expenses
-
-
-
-442,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme